Pharma & Biopharma Manufacturing
Chance Pharmaceuticals and Huadong Medicine Partner for Exclusive Commercialisation of CXG87 in China
Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhala...
October 10, 2025 | News
AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines in...
October 10, 2025 | News
Asia-Pacific Takes the Lead in Global Biopharma Resilience: Cytiva’s 2025 Index Highlights Regional Rise Amid Global Slowdown
The 2025 Global Biopharma Index released by Cytiva, a Danaher company, reveals that while the global biopharma ecosystem has experienced a modest decline i...
October 08, 2025 | Analysis
Made Scientific and Streamline Bio Validate AI-Driven Robotic Platform for Cell Therapy Manufacturing
Made Scientific, a leading clinical and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, a ...
October 07, 2025 | News
RoosterBio and Secretome Therapeutics Achieve Commercial-Scale Production Milestone for Lead Cell Therapy STM-01
RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and...
October 07, 2025 | News
Lonza Expands GMP Portfolio with TheraPEAK® AmpliCell® Cytokines and 293-GT® Medium for Enhanced Cell and Gene Therapy Manufacturing
AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK&r...
October 07, 2025 | News
Turning Signals into Cures: The Big Data Blueprint for Cell Therapy Factories
Cell therapy manufacturing is entering a data-driven era, as the industry grapples with complex production processes, high costs, and the need for personal...
October 07, 2025 | Analysis
Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate Cell and Gene Therapy Access Between Japan and Australia
As the cell and gene therapy (CGT) sector moves from scientific promise to large-scale reality, collaboration between nations with strong translational and...
October 06, 2025 | News | By arcilla.fran@biopharmaapac.com
Thermo Fisher’s PPD™ Clinical Research Joins AstraZeneca BioVentureHub for R&D Partnership in Sweden
The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development ...
October 02, 2025 | News
Cell Therapies and Teijin Forge Strategic MoU to Build Asia-Pacific Cell and Gene Therapy Infrastructure
Cell Therapies Pty Ltd. (“Cell Therapies”) and Teijin Limited announced that they have signed a Memorandum of Unders...
October 02, 2025 | News
Made Scientific and Syenex Forge Partnership to Transform T Cell Therapy Manufacturing
Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in ...
October 01, 2025 | News
PromoCell Enters GMP Market with Custom Cell Culture Media Services for Clinical Applications
PromoCell GmbH, a leading global manufacturer of primary human cells and specialized cell culture media for biomedical research, announces its entry into t...
October 01, 2025 | News
Full-Life Technologies Secures US$77 Million in Series C and Debt Financing to Advance Global Radiopharmaceutical Pipeline
Series C led by Junson Capital along with new investor syndicate and existing shareholders Funding will further advance Full-Life's global radiopharmace...
September 30, 2025 | News
WuXi Biologics Launches TrueSite TI™, a Next-Generation Targeted Integration Cell Line Platform Redefining Biologics Development
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone scre...
September 29, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
